Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.
Saved in:
| Title: | Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Jeong YS; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shin JH; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim SM; Department of Physiology, Institute of Medical Science, Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea., Sohn BH; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yim SY; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea., Kim JH; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea., Shim JJ; Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea., Lee SH; Division of Hepatobiliary and Pancreas, Department of Surgery, CHA Bundang Medical Center, CHA University, Sungnam, Korea., Chun YS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai H; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kaseb A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kang KJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Korea., Eltzschig HK; Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., MacLeod AR; Ionis Pharmaceuticals, Carlsbad, CA, USA., Luo X; Ionis Pharmaceuticals, Carlsbad, CA, USA., Revenko A; Ionis Pharmaceuticals, Carlsbad, CA, USA., Kim Y; Ionis Pharmaceuticals, Carlsbad, CA, USA., Lee JS; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | Cancer communications (London, England) [Cancer Commun (Lond)] 2026 Apr 08; Vol. 46, pp. 0020. Date of Electronic Publication: 2026 Apr 08 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: eCollection Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
